Retinal Axonal Loss Begins Early in the Course of Multiple Sclerosis and Is Similar between Progressive Phenotypes

被引:95
|
作者
Gelfand, Jeffrey M. [1 ]
Goodin, Douglas S. [1 ]
Boscardin, W. John [2 ,3 ]
Nolan, Rachel [1 ]
Cuneo, Ami [1 ]
Green, Ari J. [1 ]
机构
[1] Univ Calif San Francisco, Dept Neurol, Multiple Sclerosis Ctr, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
来源
PLOS ONE | 2012年 / 7卷 / 05期
关键词
NERVE-FIBER LAYER; OPTICAL COHERENCE TOMOGRAPHY; MAGNETIC-RESONANCE-SPECTROSCOPY; BRAIN ATROPHY; WHITE-MATTER; DISABILITY; LESIONS; THICKNESS; PATHOLOGY; MS;
D O I
10.1371/journal.pone.0036847
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: To determine whether retinal axonal loss is detectable in patients with a clinically isolated syndrome (CIS), a first clinical demyelinating attack suggestive of multiple sclerosis (MS), and examine patterns of retinal axonal loss across MS disease subtypes. Methodology/Principal Findings: Spectral-domain Optical Coherence Tomography was performed in 541 patients with MS, including 45 with high-risk CIS, 403 with relapsing-remitting (RR)MS, 60 with secondary-progressive (SP)MS and 33 with primary-progressive (PP) MS, and 53 unaffected controls. Differences in retinal nerve fiber layer (RNFL) thickness and macular volume were analyzed using multiple linear regression and associations with age and disease duration were examined in a cross-sectional analysis. In eyes without a clinical history of optic neuritis (designated as "eyes without optic neuritis''), the total and temporal peripapillary RNFL was thinner in CIS patients compared to controls (temporal RNFL by -5.4 mu m [95% CI -0.9 to -9.9 mm, p = 0.02] adjusting for age and sex). The total (p = 0.01) and temporal (p = 0.03) RNFL was also thinner in CIS patients with clinical disease for less than 1 year compared to controls. In eyes without optic neuritis, total and temporal RNFL thickness was nearly identical between primary and secondary progressive MS, but total macular volume was slightly lower in the primary progressive group (p<0.05). Conclusions/Significance: Retinal axonal loss is increasingly prominent in more advanced stages of disease - progressive MS>RRMS>CIS - with proportionally greater thinning in eyes previously affected by clinically evident optic neuritis. Retinal axonal loss begins early in the course of MS. In the absence of clinically evident optic neuritis, RNFL thinning is nearly identical between progressive MS subtypes.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] OCT and Visual Field Changes as Useful Markers for Follow-up of Axonal Loss in Multiple Sclerosis in Egyptian Patients
    Khalil, Dalia H.
    Said, Mohamed M.
    Abdelhakim, Mohamad Amr Salah Eddin
    Labeeb, Dalia M.
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2017, 25 (03) : 315 - 322
  • [32] Retinal thickness as a potential biomarker of neurodegeneration and a predictor of early cognitive impairment in patients with multiple sclerosis
    Esmael, Ahmed
    Elsherif, Mohamed
    Abdelsalam, Mohamed
    Sabry, Dalia
    Mamdouh, Mohamed
    Belal, Tamer
    NEUROLOGICAL RESEARCH, 2020, 42 (07) : 564 - 574
  • [33] Evidence of retinal anterograde neurodegeneration in the very early stages of multiple sclerosis: a longitudinal OCT study
    Pietroboni, Anna M.
    Carandini, Tiziana
    Dell'Arti, Laura
    Bovis, Francesca
    Colombi, Annalisa
    De Riz, Milena A.
    Casazza, Elena
    Scola, Elisa
    Fenoglio, Chiara
    Arighi, Andrea
    Fumagalli, Giorgio G.
    Triulzi, Fabio
    Galimberti, Daniela
    Viola, Francesco
    Scarpini, Elio
    NEUROLOGICAL SCIENCES, 2020, 41 (11) : 3175 - 3183
  • [34] Optical coherence tomography in patients with a history of juvenile multiple sclerosis reveals early retinal damage
    Huhn, K.
    Laemmer, R.
    Oberwahrenbrock, T.
    Laemmer, A.
    Waschbisch, A.
    Gosar, D.
    Brandt, A.
    Paul, F.
    Linker, R. A.
    Lee, D. -H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 (01) : 86 - 92
  • [35] Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosis
    Axelsson, Markus
    Malmestrom, Clas
    Gunnarsson, Martin
    Zetterberg, Henrik
    Sundstrom, Peter
    Lycke, Jan
    Svenningsson, Anders
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (01) : 43 - 50
  • [36] Axonal Loss and Neurofilament Phosphorylation Changes Accompany Lesion Development and Clinical Progression in Multiple Sclerosis
    Schirmer, Lucas
    Antel, Jack P.
    Brueck, Wolfgang
    Stadelmann, Christine
    BRAIN PATHOLOGY, 2011, 21 (04) : 428 - 440
  • [37] Relationship Between Retinal Layer Thickness and Disability Worsening in Relapsing-Remitting and Progressive Multiple Sclerosis
    Cellerino, Maria
    Priano, Luca
    Bruschi, Nicolo
    Boffa, Giacomo
    Petracca, Maria
    Novi, Giovanni
    Lapucci, Caterina
    Sbragia, Elvira
    Uccelli, Antonio
    Inglese, Matilde
    JOURNAL OF NEURO-OPHTHALMOLOGY, 2021, 41 (03) : 329 - 334
  • [38] The loss of macular ganglion cells begins from the early stages of disease and correlates with brain atrophy in multiple sclerosis patients
    Pietroboni, Anna M.
    Dell'Arti, Laura
    Caprioli, Michela
    Scarioni, Marta
    Carandini, Tiziana
    Arighi, Andrea
    Ghezzi, Laura
    Fumagalli, Giorgio G.
    De Riz, Milena A.
    Basilico, Paola
    Colombi, Annalisa
    Benatti, Eleonora
    Triulzi, Fabio
    Scarpini, Elio
    Viola, Francesco
    Galimberti, Daniela
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (01) : 31 - 38
  • [39] Progressive changes in the retinal nerve fiber layer in patients with multiple sclerosis
    Garcia-Martin, Elena
    Pueyo, Victoria
    Martin, Jesus
    Almarcegui, Carmen
    Ara, Jose R.
    Dolz, Isabel
    Honrubia, Francisco M.
    Fernandez, Francisco J.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2010, 20 (01) : 167 - 173
  • [40] Early imaging predicts later cognitive impairment in primary progressive multiple sclerosis
    Penny, S.
    Khaleeli, Z.
    Cipolotti, L.
    Thompson, A.
    Ron, M.
    NEUROLOGY, 2010, 74 (07) : 545 - 552